Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cheryl F. Lichti"'
Autor:
Cheryl F. Lichti, Nathalie Vigneron, Karl R. Clauser, Benoit J. Van den Eynde, Michal Bassani-Sternberg
Publikováno v:
Cancer immunology research, (2022)
Within the tumor immunology community, the topic of proteasomal spliced peptides (PSP) has generated a great deal of controversy. In the earliest reports, careful biological validation led to the conclusion that proteasome-catalyzed peptide splicing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9066c16e787e09c982b969fd0538a4a
https://hdl.handle.net/2078.1/259032
https://hdl.handle.net/2078.1/259032
Autor:
Maxim N. Artyomov, Daniele Runci, Ilya Kizhvatov, Ruan F.V. Medrano, Kai W. Wucherpfennig, Danielle M. Lussier, Wei Meng, Cheryl F. Lichti, Kathleen C. F. Sheehan, Jeffrey P. Ward, Tyler Jacks, Alexander Chen, Adrienne M. Luoma, J. Michael White, Elise Alspach, Alexander P. Miceli, Matthew M. Gubin, Emil R. Unanue, Robert D. Schreiber, Michel DuPage, Ekaterina Esaulova, Anthony N. Vomund, Cora D. Arthur
Publikováno v:
PMC
Nature
Nature
The ability of the immune system to eliminate and shape the immunogenicity of tumours defines the process of cancer immunoediting1. Immunotherapies such as those that target immune checkpoint molecules can be used to augment immune-mediated eliminati
Autor:
Richard D. LeDuc, Cheryl F. Lichti, Joseph R. Moskal, Mary F. Schmidt, Roger A. Kroes, Carol L. Nilsson, Norelle C. Wildburger
Publikováno v:
EuPA Open Proteomics, Vol 8, Iss C, Pp 94-103 (2015)
Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) show promise as cell-based delivery vehicles for anti-glioma therapeutics, due to innate tropism for gliomas. However, in clinically relevant human-in-mouse glioma stem cell xenograft models
Autor:
Alexander V. Chervonsky, Orion J. Peterson, Emil R. Unanue, Xiaoxiao Wan, Anthony N. Vomund, Cheryl F. Lichti
Publikováno v:
Nature Immunology. 21:589-589
Autor:
Ekaterina Mostovenko, György Marko-Varga, Frederick F. Lang, Cheryl F. Lichti, David Fenyö, Qianghu Wang, Ákos Végvári, Erik P. Sulman, K. Barbara Sahlin, Melinda Rezeli, Carol L. Nilsson
Glioblastoma (GBM), the most malignant of primary brain tumors, is a devastating and deadly disease, with a median survival of 14 months from diagnosis, despite standard regimens of radical brain tumor surgery, maximal safe radiation, and concomitant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34398b5f64d13681444d98be64674d7
https://europepmc.org/articles/PMC6008157/
https://europepmc.org/articles/PMC6008157/
Autor:
Jasreet Hundal, Jacqueline E. Payton, Chris Harris, Timothy J. Ley, Jason Walker, Mark A. Watson, Cyriac Kandoth, Rakesh Nagarajan, Qunyuan Zhang, Ling Lin, Elaine R. Mardis, Joshua J. Conyers, Patricia A. Alldredge, Cheryl F. Lichti, Michael D. McLellan, Robert S. Fulton, John S. Welch, Daniel C. Link, Sean McGrath, William D. Shannon, Vincent Magrini, John R. Osborne, Sharon Heath, Joshua F. McMichael, Richard K. Wilson, Peter Westervelt, Li Ding, Tammi L. Vickery, Jack Baty, R. Reid Townsend, Tamara Lamprecht, Lisa Cook, Timothy A. Graubert, David J. Dooling, Nobish Varghese, Matthew J. Walter, Todd Wylie, Lucinda Fulton, Daniel C. Koboldt, John F. DiPersio, Joelle Kalicki, Gary W. Swift, Michelle O'Laughlin, Jerry P. Reed, Michael H. Tomasson, Kim D. Delehaunty, Heather Schmidt, David E. Larson
Publikováno v:
New England Journal of Medicine. 363:2424-2433
BACKGROUND The genetic alterations responsible for an adverse outcome in most patients with acute myeloid leukemia (AML) are unknown. METHODS Using massively parallel DNA sequencing, we identified a somatic mutation in DNMT3A, encoding a DNA methyltr
Autor:
Cheryl F. Lichti, Eric A. Wold, Charles S. Umbaugh, Carol L. Nilsson, Marxa L. Figueiredo, Joseph J. Shearer
Publikováno v:
Environmental Health Perspectives
Background: The tumor microenvironment plays an important role in the progression of cancer by mediating stromal–epithelial paracrine signaling, which can aberrantly modulate cellular proliferation and tumorigenesis. Exposure to environmental toxic
Autor:
Mark R. Emmett, Paul L. Wood, Norelle C. Wildburger, Carol L. Nilsson, Cheryl F. Lichti, Frederick F. Lang, Joy Gumin
Publikováno v:
Journal of proteome research. 14(6)
Glioblastoma (GBM) is the most common adult primary brain tumor. Despite aggressive multimodal therapy, the survival of patients with GBM remains dismal. However, recent evidence has demonstrated the promise of bone marrow-derived mesenchymal stem ce
Autor:
Ekaterina Mostovenko, Ákos Végvári, Kelly V. Ruggles, Cheryl F. Lichti, David Fenyö, Carol L. Nilsson, Erik P. Sulman
Recurrence of primary GBM is nearly inevitable and recurrent tumors are often more aggressive than the primary tumor. State-of-the-art sequencing and analysis methods have been applied to many tumor types, including GBM. While a large number of studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e99ed3225e26c2c11f674c6ab09322
https://europepmc.org/articles/PMC4218583/
https://europepmc.org/articles/PMC4218583/
Autor:
Gregory A. Taylor, Barbara A. Fox, Sarah J. Fentress, Michael S. Behnke, Benjamin E. Turk, Cheryl F. Lichti, Leah M. Rommereim, Raymond Hui, R. Reid Townsend, Ildiko Rita Dunay, L. David Sibley, David J. Bzik, Mona Mashayekhi, Wandy L. Beatty, Wei Qiu
Publikováno v:
Cell Host & Microbe. (6):484-495
SummaryMacrophages are specialized to detect and destroy intracellular microbes and yet a number of pathogens have evolved to exploit this hostile niche. Here we demonstrate that the obligate intracellular parasite Toxoplasma gondii disarms macrophag